KRKA, d.d., Novo Mesto (responsible for full manufacturing cycle, including batch release)/KRKA, d.d., Novo Mesto (responsible for batch control)

Ukraine

All drugs from this manufacturer

  • MOFLAXA

    The drug is prescribed for the treatment of bacterial infections, including acute bacterial sinusitis, exacerbation of chronic obstructive pulmonary disease (including bronchitis), non-hospital pneumonia, and inflammatory diseases of the pelvic organs (under certain conditions).

    Dosage form: tablets, film-coated

    Active substance Dosage
    moxifloxacin 400 mg

    ATC: J01MA14